| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.1 | 0.05 |